Magnesium Supplementation in Adults
Recommended Daily Intake
The recommended dietary allowance (RDA) for magnesium is 320 mg/day for women and 420 mg/day for men, with approximately half of US adults consuming less than this amount from food sources. 1, 2
- Dietary magnesium intake is inversely associated with chronic inflammatory stress, hypertension, ischemic heart disease, stroke, metabolic syndrome, type 2 diabetes, and colorectal cancer 3, 2
- Serum magnesium does not reflect intracellular magnesium (which comprises >99% of total body stores), making most cases of deficiency undiagnosed 4
- Marginal magnesium deficiency affects 15-20% of the population, with mean daily intake around 4 mg/kg/day versus the recommended 6 mg/kg/day 5
High-Risk Populations Requiring Supplementation
Older Adults
- Elderly individuals may benefit from magnesium supplementation at the RDA level, particularly those on calorie-restricted diets 6, 1
- Malnourished older patients starting enteral or parenteral nutrition require magnesium monitoring and supplementation even for mild deficiency during the first 72 hours to prevent refeeding syndrome 1
Gastrointestinal Disorders
Patients with short bowel syndrome, particularly those with jejunostomy, experience significant magnesium losses requiring supplementation, with rehydration to correct secondary hyperaldosteronism as the crucial first step before supplementation. 1
- Magnesium deficiency occurs in 13-88% of patients with inflammatory bowel disease 1
- Administer magnesium oxide 12-24 mmol daily (approximately 480-960 mg elemental magnesium), preferably at night when intestinal transit is slowest 1
- If oral supplements fail to normalize levels, consider oral 1-alpha hydroxy-cholecalciferol (0.25-9.00 μg daily) to improve magnesium balance, monitoring serum calcium regularly 1
- Intravenous or subcutaneous magnesium sulfate (4-12 mmol added to saline bags) may be necessary when oral supplementation is ineffective 1
Proton Pump Inhibitor (PPI) Users
- PPIs cause renal magnesium losses and are a recognized cause of hypomagnesemia 7
- Consider discontinuing PPIs or switching to alternatives when possible in patients with documented hypomagnesemia 1
- Monitor magnesium levels every 3 months in patients requiring long-term PPI therapy 1
Type 2 Diabetes
There is no clear evidence of benefit from magnesium supplementation in people with diabetes compared with the general population who do not have underlying deficiencies. 6
- Chromium, potassium, magnesium, and possibly zinc deficiency may aggravate carbohydrate intolerance, but well-designed studies have failed to demonstrate significant benefit of chromium or magnesium supplementation in individuals with type 2 diabetes 6
- Health care providers should focus on nutrition counseling rather than micronutrient supplementation to reach metabolic control 6
- Routine supplementation with magnesium is not advised without documented deficiency 6
Supplementation Formulations and Dosing
Oral Magnesium Oxide
- The American Gastroenterological Association conditionally recommends magnesium oxide for adults with chronic idiopathic constipation who have failed other therapies, starting at 400-500 mg daily and titrating based on response. 1
- FDA-approved dosing: 1 tablet twice daily as antacid, or 1-2 tablets daily as magnesium supplement 8
- Magnesium oxide provides approximately 480 mg elemental magnesium at 800 mg/day total dose 1
- Causes more osmotic diarrhea than organic salts due to poor absorption 1
Organic Magnesium Salts
- Organic magnesium salts (aspartate, citrate, lactate) have superior bioavailability compared to magnesium oxide or hydroxide and cause fewer gastrointestinal side effects. 1
- Liquid or dissolvable magnesium products are usually better tolerated than pills 1
- Magnesium citrate FDA dosing for adults: 6.5-10 fl oz as single daily dose or divided doses (maximum 10 fl oz in 24 hours) 9
Intravenous Magnesium
- For severe symptomatic hypomagnesemia (<0.50 mmol/L), give 1-2 g magnesium sulfate IV bolus over 5-15 minutes, followed by continuous infusion 7
- For torsades de pointes with prolonged QT interval, give 1-2 g magnesium sulfate IV bolus over 5 minutes regardless of baseline magnesium level 7
- Maximum rate should not exceed 150 mg/minute except in severe eclampsia with seizures 1
Critical Precautions and Contraindications
Renal Insufficiency
Magnesium supplementation is absolutely contraindicated when creatinine clearance is <20 mL/min due to risk of life-threatening hypermagnesemia. 1, 7
- Use reduced doses with close monitoring when creatinine clearance is 30-60 mL/min 1
- Avoid magnesium between 20-30 mL/min creatinine clearance except in life-threatening emergencies (torsades de pointes), and only with close monitoring 1
- Check renal function before initiating any magnesium supplementation 1
Common Side Effects
- Diarrhea, abdominal distension, and gastrointestinal intolerance are the most common side effects 1
- Most magnesium salts are poorly absorbed and may paradoxically worsen diarrhea or stomal output in patients with gastrointestinal disorders 1
- Start at lower doses and increase gradually according to tolerance 1
Monitoring Guidelines
Standard Monitoring Timeline
- Check magnesium levels 2-3 weeks after starting oral supplementation or after any dose adjustment 1
- Once on stable dosing, monitor every 3 months 1
- More frequent monitoring required if high GI losses, renal disease, or on medications affecting magnesium (diuretics, PPIs, calcineurin inhibitors) 1
Special Populations
- Patients with short bowel syndrome or high gastrointestinal losses: check levels every 2 weeks during first 3 months 1
- Patients on continuous renal replacement therapy: check levels every other week initially 1
- Post-renal transplant patients on calcineurin inhibitors: check weekly initially, then every 2-4 weeks once stable 10
Treatment Algorithm for Hypomagnesemia
Step 1: Correct Underlying Factors
- First correct water and sodium depletion with IV normal saline (2-4 L/day initially) to address secondary hyperaldosteronism, which increases renal magnesium wasting and prevents effective oral repletion. 1, 7
- Discontinue offending medications when possible (diuretics, PPIs, calcineurin inhibitors) 1
Step 2: Oral Supplementation for Mild-Moderate Deficiency
- Administer magnesium oxide 12-24 mmol daily (approximately 480-960 mg elemental magnesium) 1
- Give magnesium at night when intestinal transit is slowest to improve absorption 1
- For better tolerance, consider organic magnesium salts (citrate, aspartate, lactate) 1
Step 3: Parenteral Therapy for Severe or Refractory Cases
- For severe symptomatic hypomagnesemia or when oral therapy fails, use IV or subcutaneous magnesium sulfate 1, 7
- Administer 4-12 mmol magnesium sulfate added to saline bags 1-3 times weekly 1
Step 4: Address Refractory Hypokalemia and Hypocalcemia
- Always replace magnesium before attempting to correct hypocalcemia or hypokalemia, as these will be refractory to treatment until magnesium is normalized. 1, 7
- Hypomagnesemia causes dysfunction of multiple potassium transport systems and increases renal potassium excretion 1
- Calcium normalization typically occurs within 24-72 hours after magnesium repletion begins 1
Common Pitfalls to Avoid
- Never attempt to correct hypokalemia or hypocalcemia before normalizing magnesium—these electrolyte abnormalities are refractory to supplementation until magnesium is corrected 1
- Failing to correct volume depletion first will result in continued magnesium losses despite supplementation due to ongoing hyperaldosteronism 1
- Assuming normal serum magnesium excludes deficiency—less than 1% of total body magnesium is in blood, so normal levels can coexist with significant intracellular depletion 1
- Using hypotonic oral fluids (tea, coffee, juices) in patients with jejunostomy causes sodium and magnesium loss from the gut 1
- Administering calcium and iron supplements together with magnesium inhibits absorption—separate by at least 2 hours 7